![Jian Irish](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jian Irish
President at METAGENOMI, INC.
Net worth: 4 M $ as of 31/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jak Knowles | M | - |
Affini-T Therapeutics, Inc.
![]() Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | 5 years |
Brian Thomas | M | 55 | 8 years | |
Patrick Kron | M | 70 | 10 years | |
Simren Delaney | M | 38 | 4 years | |
Jürgen Eckhardt | M | 57 | 4 years | |
Arjun Goyal | M | - |
Affini-T Therapeutics, Inc.
![]() Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | 3 years |
Alexandra Roger | F | - | 8 years | |
Michael Conway | M | 48 | 2 years | |
Christopher Brown | M | 35 | 1 years | |
Pamela Wapnick | F | 58 | 1 years | |
Brendan OCallaghan | M | 62 | 9 years | |
Simon Harnest | M | 37 | 3 years | |
Risa Stack | M | 55 | 2 years | |
Luis Borges | M | 62 | 1 years | |
Willard Dere | M | 70 | 3 years | |
Sebastián Bernales | M | 48 | 4 years | |
Sarah Noonberg | M | 56 | 1 years | |
Alan Brooks | M | 58 | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bonnie Bassler | M | 61 | 2 years | |
Claire Massiot-Jouault | F | 62 | 5 years | |
Christopher Viehbacher | M | 64 | 6 years | |
Klaus Pohle | M | 86 | 12 years | |
Olivier Brandicourt | M | 68 | 4 years | |
Arthur Charles V. Wellesley | M | 78 | 12 years | |
Thierry Desmarest | M | 78 | 14 years | |
Philippe Pierre Goupit | M | - | 20 years | |
Mishima Gerhart | F | - | 6 years | |
Mahalakshmi Radhakrishnan | M | - | 3 years | |
Christian Antoni | M | 62 | - | |
Santhosh Palani | M | 41 | 2 years | |
Michael Kamarck | M | 73 | - | |
Léopold Bertea | M | 60 | 6 years | |
Ruchita Sinha | F | - | 3 years | |
Andrew Levin | M | - | - | |
Venkat Reddy | M | - | 4 years | |
Robert Sebbag | M | 73 | 10 years | |
Antoine Delcour | M | - | 6 years | |
Sarah Holland | F | 61 | 2 years | |
Suresh Kumar | M | 69 | - | |
Adrian Senderowicz | M | 60 | 1 years | |
Maya Said | M | 47 | 4 years | |
Alexandra Rocca | F | 61 | - | |
Jean-François Brin | M | 60 | 6 years | |
Anne Michelle Whitaker | F | 56 | 3 years | |
David-Alexandre Gros | M | 51 | 4 years | |
Paul Herbert Chew | M | 72 | 3 years | |
Anne Beal | M | 62 | - | |
Matthew Ros | M | 57 | 2 years | |
Carsten Hellmann | M | 60 | 3 years | |
Igor Landau | M | 78 | 11 years | |
Ailsa Dalgliesh | F | - |
Affini-T Therapeutics, Inc.
![]() Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 33 | 64.71% |
United States | 18 | 35.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jian Irish
- Personal Network